The use of orthopaedic shoes in patients with diabetes at high risk of foot amputation and Charcot arthropathy

被引:0
|
作者
Demina, A. G. [1 ,2 ]
Bregovskiy, V. B. [1 ,2 ]
Karpova, I. A. [2 ]
机构
[1] Federal North West Med Res Ctr, St Petersburg, Russia
[2] City Diabet Ctr, St Petersburg, Russia
来源
DIABETES MELLITUS | 2015年 / 18卷 / 04期
关键词
diabetes mellitus; diabetic foot; orthopedic footwear; diabetic neuroosteoarthropathia; Charcot foot;
D O I
10.14341/DM7186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To evaluate the use of orthopaedic shoes in patients with diabetes with foot ulcers and/or previous minor amputations or Charcot arthropathy (CA) and factors influencing this use. Patients and methods. One hundred twenty-one patients with diabetes (55 men and 66 women; 36 in the inactive stage of CA) were included. A questionnaire based on footwear was used to evaluate patients' compliance. Daily activity and the severity of the foot deformities were recorded. Further, foot geometry and forefoot and midfoot circumferences were measured. Results. Fifty-eight patients did not use orthopaedic shoes. Users and non-users did not differ in terms of gender and type of diabetes. The causes of refusal included ill-fitting shoes (56%), ugly appearance (11%), traumatisation with shoes (11%), inability to walk (5%) and other causes (17%). The percentages of patients in each category of deformity severity were mild (41.2%), moderate (37%) and severe (54%. Frequency of refusal of CA vs non-CA patients: 72.2% and 43.5%; with severe deformities, 70.8% vs 34%; with moderate deformities, 83.3% vs 57.2% (p < 0.05 for all). In patients with CA, the only significant parameter was the difference in the circumference of the midfoot between the affected and non-affected foot; in CA users and non-users, this parameter was 1.93 +/- 1.25 vs 0.70 +/- 0.83 cm, respectively (p = 0.01). Conclusions. The high frequency of refusing to wear orthopaedic shoes is related to severe foot deformities and the inability to accommodate them in off-the-shelf footwear. Most of the patients used orthopaedic shoes for outdoor use, but the frequency of use was low. Shoe compliance did not depend on gender but increased with ageing, low levels of daily activity and in patients with severe deformities. Patients with CA are characterised with extremely low compliance. In this group, foot parameters and other objective parameters did not rely on footwear compliance.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [41] Amputation and infection are the greatest fears in patients with diabetes foot complications
    Wukich, Dane K.
    Raspovic, Katherine M.
    Jupiter, Daniel C.
    Heineman, Nathan
    Ahn, Junho
    Johnson, Matthew J.
    Liu, George T.
    VanPelt, Michael D.
    Lafontaine, Javier
    Lavery, Larry
    Kim, Paul
    Nakonezny, Paul A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (07)
  • [42] AMPUTATION THROUGH THE FOOT IN PATIENTS WITH DIABETES-MELLITUS OR ARTERIOSCLEROSIS
    BJORNSSON, HA
    STENSTROM, A
    LINDSTRAND, A
    ACTA ORTHOPAEDICA SCANDINAVICA, 1984, 55 (06): : 685 - 685
  • [43] USE OF CUSTOM-MADE SHOES IN PATIENTS WITH FOOT DEFORMITIES
    Chadchavalpanichaya, Navaporn
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S115 - S115
  • [44] Risk Reduction and Perioperative Complications in Patients With Diabetes and Multiple Medical Comorbidities Undergoing Charcot Foot Reconstruction
    Lyons, Madeline
    McGregor, Patrick Cole
    Pinzur, Michael S.
    Adams, William
    Wilkos-Prostran, Lynette
    FOOT & ANKLE INTERNATIONAL, 2021, 42 (07) : 902 - 909
  • [45] How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?
    Saltzman, CL
    Hagy, ML
    Zimmerman, B
    Estin, M
    Cooper, R
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (435) : 185 - 190
  • [46] Foot insensitivity and risk of foot ulcer or lower extremity amputation in diabetes: The strong heart study
    Carter, Elizabeth A.
    Sosenko, Jay M.
    Howard, Barbara V.
    Resnick, Helaine E.
    DIABETES, 2006, 55 : A243 - A243
  • [47] Prevalence and risk factors of Charcot Foot in patients with Diabetic Neuropathy
    Elsayed, Enas
    Edrees, Khalid
    Al Nahdi, Orjwan
    Al Jmai, Reham
    Rehab, Nagwa Ibrahim
    BIOSCIENCE RESEARCH, 2020, 17 (03): : 2101 - 2106
  • [48] Risk factors for development of nephropathy in patients with a diabetic Charcot foot
    Rasmus Bo Jansen
    Per E. Holstein
    Bo Jørgensen
    Klaus Kirketerp Møller
    Ole Lander Svendsen
    BMC Research Notes, 14
  • [49] Development of Predictive Nomograms for Clinical Use to Quantify the Risk of Amputation in Patients with Diabetic Foot Ulcer
    Peng, Bocheng
    Min, Rui
    Liao, Yiqin
    Yu, Aixi
    JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [50] Risk factors for development of nephropathy in patients with a diabetic Charcot foot
    Jansen, Rasmus Bo
    Holstein, Per E.
    Jorgensen, Bo
    Moller, Klaus Kirketerp
    Svendsen, Ole Lander
    BMC RESEARCH NOTES, 2021, 14 (01)